Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
« Il y a urgence à agir » : le gouvernement veut cadrer l’usage de l’IA dans la fonction publique Face au « danger » d’une technologie « clandestine », notamment, l’exécutif veut mener une « ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results